232 related articles for article (PubMed ID: 12404039)
1. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
Kulow BF; Cualing H; Steele P; VanHorn J; Breneman JC; Mutasim DF; Breneman DL
J Cutan Med Surg; 2002; 6(6):519-28. PubMed ID: 12404039
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma versus pseudolymphoma of the skin: gene rearrangement study of 21 cases with clinicopathologic correlation.
Landa NG; Zelickson BD; Peters MS; Muller SA; Pittelkow MR
J Am Acad Dermatol; 1993 Dec; 29(6):945-53. PubMed ID: 8245259
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features.
Kazakov DV; Burg G; Kempf W
Cesk Patol; 2002 Oct; 38(4):147-54. PubMed ID: 12629860
[TBL] [Abstract][Full Text] [Related]
4. Disseminated cutaneous B-cell lymphoma mimicking pseudolymphoma over a period of six years.
Gutermuth J; Audring H; Roseeuw D
Am J Dermatopathol; 2004 Jun; 26(3):225-9. PubMed ID: 15166512
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction-based clonality analysis of cutaneous B-cell lymphoproliferative processes.
Melotti CZ; Amary MF; Sotto MN; Diss T; Sanches JA
Clinics (Sao Paulo); 2010; 65(1):53-60. PubMed ID: 20126346
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
[TBL] [Abstract][Full Text] [Related]
8. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
Bergman R
Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
[TBL] [Abstract][Full Text] [Related]
9. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
Levy E; Godet J; Cribier B; Lipsker D
Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
[TBL] [Abstract][Full Text] [Related]
10. Pseudolymphoma evolving into diffuse large B-cell lymphoma.
Anandasabapathy N; Pulitzer M; Epstein W; Rosenman K; Latkowski JA
Dermatol Online J; 2008 May; 14(5):22. PubMed ID: 18627758
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of primary and secondary cutaneous B-cell lymphoma by Southern blot analysis.
Sepp N; Weyer K; Haun M; Zelger B; Thaler J; Faber V; Fritsch P; Grünewald K
Am J Clin Pathol; 1996 Dec; 106(6):749-57. PubMed ID: 8980350
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Pseudolymphoma.
Mitteldorf C; Kempf W
Surg Pathol Clin; 2017 Jun; 10(2):455-476. PubMed ID: 28477891
[TBL] [Abstract][Full Text] [Related]
14. The skin-associated lymphoid tissue-related B-cell lymphomas.
Pimpinelli N; Santucci M
Semin Cutan Med Surg; 2000 Jun; 19(2):124-9. PubMed ID: 10892714
[TBL] [Abstract][Full Text] [Related]
15. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma.
Bergman R; Kurtin PJ; Gibson LE; Hull PR; Kimlinger TK; Schroeter AL
Arch Dermatol; 2001 Apr; 137(4):432-9. PubMed ID: 11295923
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
Cerroni L; Goteri G
Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
[TBL] [Abstract][Full Text] [Related]
18. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Han B; Liu H; Wang H
Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
[TBL] [Abstract][Full Text] [Related]
19. Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation.
Navarrete-Dechent C; Del Puerto C; Abarzúa-Araya Á; Molgó M; Geller S; Andreani S; Cury-Martins J; Sanches JA; Montoya J; González S; Uribe P
Int J Dermatol; 2019 Nov; 58(11):1270-1276. PubMed ID: 31347153
[TBL] [Abstract][Full Text] [Related]
20. Heavy multinodular cutaneous lymphoid infiltrates: clinicopathologic features and B-cell clonality.
Ceballos KM; Gascoyne RD; Martinka M; Trotter MJ
J Cutan Pathol; 2002 Mar; 29(3):159-67. PubMed ID: 11972713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
